Literature DB >> 31073909

Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary center and comparison with previous studies.

Atakan Tanacan1, Erdem Fadiloglu2, Gonca Ozten2, Ali Can Gunes2, Gokcen Orgul2, Mehmet Sinan Beksac2.   

Abstract

BACKGROUND AND AIM: To share our experience with the management of pregnancies in women with myasthenia gravis (MG) in a tertiary center.
METHODS: The study retrospectively evaluated 27 pregnancies in 12 patients. The pregnancies were divided into 3 groups on the basis of the clinical course of MG during pregnancy: improvement (n = 7), disease-stable (n = 9), and deterioration (n = 11). The groups were compared with respect to patient characteristics, clinical features, and obstetric outcomes.
RESULTS: There were 4 miscarriages (14.8%), 3 preterm births (11.1%), and 4 cases of preterm premature rupture of the membranes (PPROM) (14.8%). Exacerbation was observed in 25.9% of the cases; the remission rate during the postpartum period and after miscarriage was 37%. The cesarean section (CS) rate was 78.3%. Pregnancies with deterioration of MG were statistically more likely to have higher miscarriage, preterm birth, PPROM, CS, and transient neonatal MG rates, in addition to a lower gestational age at birth, birth weight, and 5-min Apgar score than pregnancies with improved or stable disease (p values < 0.001, 0.04, 0.03, 0.009, 0.02, < 0.001, 0.002, and 0.043, respectively).
CONCLUSION: Physicians who manage pregnant women with MG must be familiar with the clinical features of the condition; a multidisciplinary approach is necessary for a better prognosis.

Entities:  

Keywords:  Acetylcholine receptors; Myasthenia gravis; Neuromuscular junction; Obstetric complications; Pregnancy

Mesh:

Year:  2019        PMID: 31073909     DOI: 10.1007/s11845-019-02029-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  35 in total

1.  Geographical distribution of a seropositive myasthenia gravis population.

Authors:  Anne Taraldsen Heldal; Geir Egil Eide; Nils Erik Gilhus; Fredrik Romi
Journal:  Muscle Nerve       Date:  2012-06       Impact factor: 3.217

2.  Multivariate determinants of the need for postoperative ventilation in myasthenia gravis.

Authors:  M Naguib; A A el Dawlatly; M Ashour; E A Bamgboye
Journal:  Can J Anaesth       Date:  1996-10       Impact factor: 5.063

3.  Behcet's disease and pregnancy: what to expect?

Authors:  Gokcen Orgul; Fatih Aktoz; Mehmet Sinan Beksac
Journal:  J Obstet Gynaecol       Date:  2017-08-17       Impact factor: 1.246

Review 4.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

5.  [Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase].

Authors:  C Ramirez; J de Seze; O Delrieu; T Stojkovic; S Delalande; F Fourrier; D Leys; L Defebvre; A Destée; P Vermersch
Journal:  Rev Neurol (Paris)       Date:  2006-03       Impact factor: 2.607

6.  Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy.

Authors:  C J Lockwood; N Radunovic; D Nastic; S Petkovic; S Aigner; G S Berkowitz
Journal:  J Perinat Med       Date:  1996       Impact factor: 1.901

7.  Myasthenia gravis in pregnancy: Experience of a portuguese center.

Authors:  António Costa Braga; Clara Pinto; Ernestina Santos; Jorge Braga
Journal:  Muscle Nerve       Date:  2016-07-14       Impact factor: 3.217

Review 8.  International consensus guidance for management of myasthenia gravis: Executive summary.

Authors:  Donald B Sanders; Gil I Wolfe; Michael Benatar; Amelia Evoli; Nils E Gilhus; Isabel Illa; Nancy Kuntz; Janice M Massey; Arthur Melms; Hiroyuki Murai; Michael Nicolle; Jacqueline Palace; David P Richman; Jan Verschuuren; Pushpa Narayanaswami
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

9.  Retrospective evaluation of pregnant women with celiac disease.

Authors:  Kemal Beksaç; Gökçen Örgül; Murat Çağan; Ergun Karaağaoğlu; Serap Arslan; Mehmet Sinan Beksaç
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-03-15

Review 10.  Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Authors:  Nico Melzer; Tobias Ruck; Peter Fuhr; Ralf Gold; Reinhard Hohlfeld; Alexander Marx; Arthur Melms; Björn Tackenberg; Berthold Schalke; Christiane Schneider-Gold; Fritz Zimprich; Sven G Meuth; Heinz Wiendl
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

View more
  3 in total

1.  Myasthenia gravis in pregnancy: Systematic review and case series.

Authors:  Harrison Banner; Kirsten M Niles; Michelle Ryu; Mathew Sermer; Vera Bril; Kellie E Murphy
Journal:  Obstet Med       Date:  2022-01-10

Review 2.  Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child.

Authors:  Nils Erik Gilhus
Journal:  Front Neurol       Date:  2020-06-12       Impact factor: 4.003

Review 3.  Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysis.

Authors:  Manqiqige Su; Xiaoqing Liu; Liang Wang; Jie Song; Zhirui Zhou; Sushan Luo; Chongbo Zhao
Journal:  Orphanet J Rare Dis       Date:  2022-02-16       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.